Anaphylaxis

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Hypersensitivity, Immune System Diseases

Treatments and conditions

Anaphylaxis
Treatment and conditionWhere it standsTrials
"Rush" regimen for anaphylaxisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
FMXIN002 double dose + FMXIN002 double dose + NAC + FMXIN002 single dose + FMXIN002 single dose + NAC + Epinephrine for anaphylaxisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Omalizumab for anaphylaxisTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Peanut for anaphylaxisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Peanut oral immunotherapy for anaphylaxisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.